| 國立成功大學 |
2021 |
Prognostic roles of braf, kit, nras, igf2r and sf3b1 mutations in mucosal melanomas
|
Wróblewska, J.P.;Dias-Santagata, Dias-Santagata D.;Ustaszewski, A.;Wu, C.-L.;Fujimoto, M.;Selim, M.A.;Biernat, W.;Ryś, J.;Marszalek, A.;Hoang, M.P. |
| 臺大學術典藏 |
2018 |
Prognostic roles of mRNA expression o f peroxiredoxins in lung cancer
|
Chen, Falin; FALIN CHEN; Zhang, Qiuqin; Yang, Xiaojun; Chen, Liangyuan; Huang, Chunli |
| 臺大學術典藏 |
2017 |
Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
|
Wu J.-F.; Wu J.-F.;Hsiu-Hao Chang;Lu M.-Y.;Jou S.-T.;Chang K.-C.;Ni Y.-H.;Chang M.-H.; HSIU-HAO CHANG; Lu M.-Y.; Jou S.-T.; Chang K.-C.; Ni Y.-H.; Chang M.-H. |
| 臺大學術典藏 |
2020-12-21T01:08:29Z |
Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
|
Chang M.-H.; Ni Y.-H.; Chang K.-C.; Jou S.-T.; Lu M.-Y.; Jia-Feng Wu;Chang H.-H.;Lu M.-Y.;Jou S.-T.;Chang K.-C.;Ni Y.-H.;Chang M.-H.; JIA-FENG WU; Chang H.-H. |
| 臺大學術典藏 |
2020-12-28T08:14:13Z |
Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
|
Chang M.-H.; YEN-HSUAN NI; Chang K.-C.; Wu J.-F.; Chang H.-H.; Lu M.-Y.; Jou S.-T.; Wu J.-F.;Chang H.-H.;Lu M.-Y.;Jou S.-T.;Chang K.-C.;Yen-Hsuan Ni;Chang M.-H. |
| 臺大學術典藏 |
2021-01-04T07:32:18Z |
Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
|
Ni Y.-H.; MEI-HWEI CHANG; Wu J.-F.;Chang H.-H.;Lu M.-Y.;Jou S.-T.;Chang K.-C.;Ni Y.-H.;Mei-Hwei Chang; Wu J.-F.; Chang H.-H.; Lu M.-Y.; Jou S.-T.; Chang K.-C. |
| 臺大學術典藏 |
2021-01-05T02:28:49Z |
Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
|
Wu J.-F.;Chang H.-H.;Lu M.-Y.;Shiann-Tang Jou;Chang K.-C.;Ni Y.-H.;Chang M.-H.; Wu J.-F.; Chang H.-H.; Lu M.-Y.; SHIANN-TANG JOU; Chang K.-C.; Ni Y.-H.; Chang M.-H. |
| 臺大學術典藏 |
2021-07-22T08:13:28Z |
Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
|
Wu J.-F.; Chang H.-H.; Lu M.-Y.; Jou S.-T.; KAI-CHI CHANG; Ni Y.-H.; Chang M.-H. |
| 臺大學術典藏 |
2020-12-16T07:21:49Z |
Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
|
Wu J.-F.;Chang H.-H.;Meng-Yao Lu;Jou S.-T.;Chang K.-C.;Ni Y.-H.;Chang M.-H.; Wu J.-F.; Chang H.-H.; MENG-YAO LU; Jou S.-T.; Chang K.-C.; Ni Y.-H.; Chang M.-H. |
| 臺大學術典藏 |
2018-09-10T18:02:00Z |
Prognostic roles of pathology markers immunoexpression and clinical parameters in hepatoblastoma.
|
Jia-Feng Wu; JIA-FENG WU |
| 臺大學術典藏 |
2017 |
Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis
|
Lee C.-S.;Kimura A.;Wu J.-F.;Ni Y.-H.;Hong-Yuan Hsu;Chang M.-H.;Nittono H.;Chen H.-L.; Lee C.-S.; Kimura A.; Wu J.-F.; Ni Y.-H.; HONG-YUAN HSU; Chang M.-H.; Nittono H.; Chen H.-L. |
| 臺大學術典藏 |
2017 |
Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis
|
Nittono H.; HUEY-LING CHEN; Lee C.-S.;Kimura A.;Wu J.-F.;Ni Y.-H.;Hsu H.-Y.;Chang M.-H.;Nittono H.;Huey-Ling Chen; Lee C.-S.; Kimura A.; Wu J.-F.; Ni Y.-H.; Hsu H.-Y.; Chang M.-H. |
| 臺大學術典藏 |
2021-01-04T07:32:19Z |
Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis
|
Lee C.-S.; Kimura A.; Wu J.-F.; Ni Y.-H.; Hsu H.-Y.; MEI-HWEI CHANG; Nittono H.; Chen H.-L.; Lee C.-S.;Kimura A.;Wu J.-F.;Ni Y.-H.;Hsu H.-Y.;Mei-Hwei Chang;Nittono H.;Chen H.-L. |
| 臺大學術典藏 |
2020-12-21T01:08:31Z |
Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis
|
Lee C.-S.;Kimura A.;Jia-Feng Wu;Ni Y.-H.;Hsu H.-Y.;Chang M.-H.;Nittono H.;Chen H.-L.; Lee C.-S.; Kimura A.; JIA-FENG WU; Ni Y.-H.; Hsu H.-Y.; Chang M.-H.; Nittono H.; Chen H.-L. |
| 臺大學術典藏 |
2020-12-28T08:14:14Z |
Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis
|
Chen H.-L.; Nittono H.; Chang M.-H.; Hsu H.-Y.; YEN-HSUAN NI; Wu J.-F.; Kimura A.; Lee C.-S. |
| 臺大學術典藏 |
2018-09-10T18:00:50Z |
Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis.
|
Jia-Feng Wu; JIA-FENG WU |
| 中國醫藥大學 |
2004-03 |
Prognostic significance a single nucleotide polymorphism in the MMP-1 promoter in chondrosarcoma.
|
馮逸卿(Fong YC); (Dutton CM); (Sim FH); (Dickey ID); (Scuiiy SP) |
| 國家衛生研究院 |
2018-12 |
Prognostic significance of 14-3-3epsilon, aldo-keto reductase family 1 B10 and metallothionein-1 in hepatocellular carcinoma
|
Wu, CY;Jan, YJ;Ko, BS;Wu, YJ;Wu, YJ;Liou, JY |
| 臺大學術典藏 |
2018-09-10T07:20:58Z |
Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide
|
Ho, Y.-L. and Lin, Y.-H. and Lee, C.-M. and Hsu, R.-B. and Ting, H.-T. and Chou, N.-K. and Chao, C.-L. and Wang, S.-S. and Hsu, H.-C. and Chen, M.-F.; Nai-Kuan Chou; CHIA-LUN CHAO; YEN-HUNG LIN; YI-LWUN HO; SHOEI-SHEN WANG; CHII-MING LEE |
| 臺大學術典藏 |
2020-03-09T07:30:52Z |
Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide
|
Ho Y.-L.; Lin Y.-H.; Lee C.-M.; Hsu R.-B.; Ting H.-T.; NAI-KUAN CHOU; Chao C.-L.; Wang S.-S.; Hsu H.-C.; Chen M.-F. |
| 臺大學術典藏 |
2020-03-10T03:08:57Z |
Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide
|
Ho Y.-L.; Lin Y.-H.; Lee C.-M.; RON-BIN HSU; Ting H.-T.; Chou N.-K.; Chao C.-L.; Wang S.-S.; Hsu H.-C.; Chen M.-F. |
| 臺大學術典藏 |
2020-12-01T07:10:22Z |
Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide
|
YI-LWUN HO; Lin Y.-H.; Lee C.-M.; Hsu R.-B.; Ting H.-T.; Chou N.-K.; Chao C.-L.; Wang S.-S.; Hsu H.-C.; Chen M.-F. |
| 臺大學術典藏 |
2020-12-04T04:19:07Z |
Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide
|
Ho Y.-L.; Lin Y.-H.; CHII-MING LEE; Hsu R.-B.; Ting H.-T.; Chou N.-K.; Chao C.-L.; Wang S.-S.; Hsu H.-C.; Chen M.-F. |
| 臺大學術典藏 |
2020-12-18T05:21:07Z |
Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide
|
Ho Y.-L.; YEN-HUNG LIN; Lee C.-M.; Hsu R.-B.; Ting H.-T.; Chou N.-K.; Chao C.-L.; Wang S.-S.; Hsu H.-C.; Chen M.-F. |
| 臺大學術典藏 |
2018-09-10T09:13:47Z |
Prognostic significance of adipocytokines in systolic heart failure patients
|
Wu, X.-M. and Lin, Y.-H. and Chen, A. and Hsu, T.-P. and Wu, Y.-W. and Lin, H.-J. and Hsu, R.-B. and Lee, C.-M. and Wang, S.-S. and Lo, M.-T. and Ho, Y.-L. and Chen, M.-F.; YEN-HUNG LIN; YI-LWUN HO; MING-FONG CHEN; SHOEI-SHEN WANG; YEN-WEN WU |
